Prevalence and effect of a combined treatment on pneumocystitis pneumonia

Nada A Elnadi1, Alzahraa E Almasry, Mostafa M Abosdera

  • 1Department of Medical Parasitology, Faculty of Medicine, Sohag University, Sohag, Egypt.

Insights

Pneumocystis pneumonia (PCP) in infants can be fatal. This study found routine treatment effective against PCP in intensive care units, though PCR was less effective for diagnosis compared to stained slides.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Pneumocystis pneumonia (PCP) poses a significant risk to critically ill infants in neonatal and pediatric intensive care units (NICU/PICU).
  • Accurate and timely diagnosis of PCP is crucial for effective treatment and improved patient outcomes.

Purpose of the Study:

  • To evaluate the efficacy of routine treatment protocols for Pneumocystis jirovecii pneumonia (PCP) in neonates and infants admitted to NICU/PICU.
  • To compare the diagnostic accuracy of Giemsa-stained sputum slides versus real-time PCR for detecting Pneumocystis jirovecii.

Main Methods:

  • Sucked sputum samples were collected from 21 pneumonic infants for Giemsa staining and real-time PCR analysis, both pre- and post-treatment.
  • Serum C-reactive protein (CRP) levels were measured on admission and discharge as an indicator of treatment response.

Main Results:

  • Pneumocystis jirovecii was detected in 12 out of 21 (57.1%) infants via sputum examination.
  • Routine treatment led to the clearance of P. jirovecii in 10 of the 12 positive cases (83.3%).
  • Real-time PCR yielded negative results for all samples, both pre- and post-treatment, contrasting with sputum microscopy findings.

Conclusions:

  • Routine treatment regimens appear effective in managing Pneumocystis pneumonia in critically ill infants.
  • Giemsa-stained sputum microscopy demonstrated higher sensitivity than real-time PCR in this cohort for diagnosing P. jirovecii.
  • Further investigation into optimized diagnostic methods for PCP in infants is warranted.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
1.0K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.2K
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
58
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K